Terrie Curran, President and Chief Executive at Phathom Pharmaceuticals, Inc. (PHAT), sold 38,218 shares at $6.59 ($252K) on 2025-01-21, disclosed to the SEC on 2025-01-23.
Open-market sale of $252k PHAT by President and Chief Executive. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.59 | 19,109 | $126K | 50.0% |
| 2 | $6.59 | 19,109 | $126K | 50.0% |
| Total | $6.59 avg | 38,218 | $252K | 100% |
| Filing → |
| ARQT | SELL | 2024-11-13 | $189K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $793K | — | Filing → |
| PHAT | SELL | 2024-03-26 | $307K | — | Filing → |